Is AstraZeneca a Buy as It Eyes the Weight Loss Market?

Medications used to treat diabetes and obesity are the hottest commodities in healthcare right now. Novo Nordisk's Ozempic and Wegovy and Eli Lilly's Mounjaro and Zepbound have all become blockbuster drugs, and their momentum doesn't seem to be going away. https://www.nasdaq.com/articles/astrazeneca-buy-it-eyes-weight-loss-market